Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution

被引:9
作者
Bellafante, Daniele [1 ]
Gioia, Stefania [1 ]
Faccioli, Jessica [1 ]
Riggio, Oliviero [1 ]
Ridola, Lorenzo [1 ]
Nardelli, Silvia [1 ]
机构
[1] Sapienza Univ Rome, Dept Translat & Precis Med, I-00185 Rome, Italy
关键词
overt hepatic encephalopathy; minimal hepatic encephalopathy; sarcopenia; portosystemic shunts; ammonia; liver cirrhosis; INTRAHEPATIC PORTOSYSTEMIC SHUNT; RETROGRADE TRANSVENOUS OBLITERATION; RANDOMIZED CONTROLLED-TRIAL; ORNITHINE L-ASPARTATE; CIRRHOTIC-PATIENTS; RISK-FACTORS; COGNITIVE IMPAIRMENT; BACTERIAL-INFECTIONS; NITROGEN-METABOLISM; REFRACTORY ASCITES;
D O I
10.3390/jcm12031187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatic encephalopathy (HE) is a common complication in patients with advanced liver disease. It is a brain dysfunction characterized by neurological and psychiatric symptoms that significantly affects quality of life, morbidity and mortality of patients. HE has various precipitants that can potentially promote its onset, alone or in combination. Among the historically well-known precipitants, such as infections, gastrointestinal bleeding, dehydration, electrolyte disorders and constipation, recent studies have highlighted the role of malnutrition and portosystemic shunts as new precipitating factors of HE. The identification, management and correction of these factors are fundamental for effective HE treatment, in addition to pharmacological therapy with non-absorbable disaccharides and/or antibiotics.
引用
收藏
页数:14
相关论文
共 112 条
[1]   Hepatic encephalopathy - Metabolic consequence of cirrhosis often is reversible [J].
Abou-Assi, S ;
Vlahcevic, ZR .
POSTGRADUATE MEDICINE, 2001, 109 (02) :52-+
[2]   Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation [J].
Alabsawy, Eman ;
Shalimar ;
Sheikh, Mohammed Faisal ;
Ballester, Maria Pilar ;
Acharya, Subrat Kumar ;
Agarwal, Banwari ;
Jalan, Rajiv .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (06) :722-732
[3]   Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance [J].
Albillos, Agustin ;
Lario, Margaret ;
Alvarez-Mon, Melchor .
JOURNAL OF HEPATOLOGY, 2014, 61 (06) :1385-1396
[4]   Novel Therapies in Hepatic Encephalopathy [J].
Alimirah, Maryam ;
Sadiq, Omar ;
Gordon, Stuart C. .
CLINICS IN LIVER DISEASE, 2020, 24 (02) :303-+
[5]   The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus [J].
Amodio, Piero ;
Bemeur, Chantal ;
Butterworth, Roger ;
Cordoba, Juan ;
Kato, Akinobu ;
Montagnese, Sara ;
Uribe, Misael ;
Vilstrup, Hendrik ;
Morgan, Marsha Y. .
HEPATOLOGY, 2013, 58 (01) :325-336
[6]   Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy [J].
An, J. ;
Kim, K. W. ;
Han, S. ;
Lee, J. ;
Lim, Y. -S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) :1418-1426
[7]   TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis [J].
Bai, Ming ;
Qi, Xing-Shun ;
Yang, Zhi-Ping ;
Yang, Man ;
Fan, Dai-Ming ;
Han, Guo-Hong .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (10) :2704-2714
[8]   Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients [J].
Bajaj, J. S. ;
Sanyal, A. J. ;
Bell, D. ;
Gilles, H. ;
Heuman, D. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (09) :1012-1017
[9]   Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial [J].
Bajaj, Jasmohan S. ;
Salzman, Nita H. ;
Acharya, Chathur ;
Sterling, Richard K. ;
White, Melanie B. ;
Gavis, Edith A. ;
Fagan, Andrew ;
Hayward, Michael ;
Holtz, Mary L. ;
Matherly, Scott ;
Lee, Hannah M. ;
Osman, Majdi ;
Siddiqui, Mohammad S. ;
Fuchs, Michael ;
Puri, Puneet ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
HEPATOLOGY, 2019, 70 (05) :1690-1703
[10]   Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial [J].
Bajaj, Jasmohan S. ;
Kassam, Zain ;
Fagan, Andrew ;
Gavis, Edith A. ;
Liu, Eric ;
Cox, I. Jane ;
Kheradman, Raffi ;
Heuman, Douglas ;
Wang, Jessica ;
Gurry, Thomas ;
Williams, Roger ;
Sikaroodi, Masoumeh ;
Fuchs, Michael ;
Alm, Eric ;
John, Binu ;
Thacker, Leroy R. ;
Riva, Antonio ;
Smith, Mark ;
Taylor-Robinson, Simon D. ;
Gillevet, Patrick M. .
HEPATOLOGY, 2017, 66 (06) :1727-1738